DHASHAINI NADARAJAH: Open Payments
NPI 1043572860 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 44 payments from 12 companies in 2025. Trend: 2023 $23 · 2024 $326 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $257 |
| ABBVIE INC. | 15 | $249 |
| Alkermes, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Lundbeck LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: Auvelity, VRAYLAR, REXULTI, ARISTADA, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, Jornay PM.
Industry payments across OH — which companies pay providers there.
